AZD4547 OPTIONS

 one prior regimen of chemotherapy for Innovative breast cancer and throughout the total demo, former exposure to any FGFR inhibitor, main surgical procedure or radiotherapy within just four weeks before to start with dose of research treatment method and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the next cardiac conditions